These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 2245010)

  • 1. Estrogen and progesterone receptors in epithelial ovarian tumours.
    Glavind K; Grove A
    APMIS; 1990 Oct; 98(10):916-20. PubMed ID: 2245010
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The positivity of estrogen receptor and progesterone receptor may not be associated with metastasis and recurrence in epithelial ovarian cancer.
    Chen S; Dai X; Gao Y; Shen F; Ding J; Chen Q
    Sci Rep; 2017 Dec; 7(1):16922. PubMed ID: 29208958
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of p53, bcl-2 and heat shock protein (hsp72) in malignant and benign ovarian tumours.
    Athanassiadou P; Petrakakou E; Sakelariou V; Zerva C; Liossi A; Michalas S; Athanassiades P
    Eur J Cancer Prev; 1998 Jun; 7(3):225-31. PubMed ID: 9696931
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic value of estrogen receptor and progesterone receptor tumor expression in Danish ovarian cancer patients: from the 'MALOVA' ovarian cancer study.
    Høgdall EV; Christensen L; Høgdall CK; Blaakaer J; Gayther S; Jacobs IJ; Christensen IJ; Kjaer SK
    Oncol Rep; 2007 Nov; 18(5):1051-9. PubMed ID: 17914554
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is endocrine status relevant to treatment planning in patients with gynaecological cancer?
    Quinn MA
    Aust N Z J Obstet Gynaecol; 1984 May; 24(2):153-7. PubMed ID: 6594131
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hormone-receptor expression status of epithelial ovarian cancer in Ibadan, South-western Nigeria.
    Ajani MA; Salami A; Awolude OA; Oluwasola AO
    Pan Afr Med J; 2017; 27():259. PubMed ID: 29187928
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinicopathological pattern of oestrogen receptor, progesterone receptor and human epidermal growth factor receptor-2 over-expression of epithelial ovarian carcinomas in Nigeria.
    Ajani MA; Lawan A; Oke T; Khramtsova G; Nwanji I; Salami A; Awolude O; Ebili H; Onwukamuche ME; Sveen E; Yoshimatsu T; Olopade OI
    Afr Health Sci; 2023 Sep; 23(3):236-244. PubMed ID: 38357171
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunohistochemical localisation of aromatase and its correlation with progesterone receptors in ovarian epithelial tumours.
    Kitawaki J; Noguchi T; Yamamoto T; Yokota K; Maeda K; Urabe M; Honjo H
    Anticancer Res; 1996; 16(1):91-7. PubMed ID: 8615676
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Absence of estrogen receptor-alpha expression in human ovarian clear cell adenocarcinoma compared with ovarian serous, endometrioid, and mucinous adenocarcinoma.
    Fujimura M; Hidaka T; Kataoka K; Yamakawa Y; Akada S; Teranishi A; Saito S
    Am J Surg Pathol; 2001 May; 25(5):667-72. PubMed ID: 11342781
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Steroid receptors and hormones in relation to cell proliferation and apoptosis in poorly differentiated epithelial ovarian tumors.
    Lindgren P; Bäckström T; Mählck CG; Ridderheim M; Cajander S
    Int J Oncol; 2001 Jul; 19(1):31-8. PubMed ID: 11408919
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Estrogen and progesterone receptors in ovarian epithelial tumors.
    Lindgren PR; Cajander S; Bäckström T; Gustafsson JA; Mäkelä S; Olofsson JI
    Mol Cell Endocrinol; 2004 Jun; 221(1-2):97-104. PubMed ID: 15223136
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical significance of hormonal receptor status of malignant ovarian tumors.
    Tkalia IG; Vorobyova LI; Svintsitsky VS; Nespryadko SV; Goncharuk IV; Lukyanova NY; Chekhun VF
    Exp Oncol; 2014 Jun; 36(2):125-33. PubMed ID: 24980769
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunohistochemical analysis of p53 protein and 72 kDa heat shock protein (HSP72) expression in ovarian carcinomas. Correlation with clinicopathology and sex steroid receptor status.
    Koshiyama M; Konishi I; Mandai M; Komatsu T; Yamamoto S; Nanbu K; Mori T
    Virchows Arch; 1995; 425(6):603-9. PubMed ID: 7697217
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of HER2/neu, estrogen and progesterone receptors, CA 125 and CA19-9 on cancer cell membrane in patients with serous and mucinous carcinoma of the ovary.
    Karaferic A; Jovanovic D; Jelic S
    J BUON; 2009; 14(4):635-9. PubMed ID: 20148455
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Estrogen and progesterone receptors in ovarian cancer.
    Harding M; Cowan S; Hole D; Cassidy L; Kitchener H; Davis J; Leake R
    Cancer; 1990 Feb; 65(3):486-91. PubMed ID: 2297640
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hormonal activity of epithelial ovarian tumours in post-menopausal women.
    Heinonen PK; Mörsky P; Aine R; Koivula T; Pystynen P
    Maturitas; 1988 Mar; 9(4):325-38. PubMed ID: 3380017
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of the contribution of immunologically-detectable HER2, steroid receptors and of the "triple-negative" tumor status to disease-free and overall survival of women with epithelial ovarian cancer.
    de Toledo MC; Sarian LO; Sallum LF; Andrade LL; Vassallo J; de Paiva Silva GR; Pinto GA; Soares FA; Fonseca CD; Derchain SF
    Acta Histochem; 2014 Apr; 116(3):440-7. PubMed ID: 24238473
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Estrogen receptors (ER) and progesterone receptors (PgR) in ovarian cancer].
    Trapani A
    Minerva Ginecol; 1992 Jun; 44(6):307-12. PubMed ID: 1635652
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of the expression of estrogen receptor, progesterone receptor and chicken ovalbumin upstream promoter-transcription factor I in ovarian epithelial cancers and normal ovaries.
    De Sousa Damião R; Fujiyama Oshima CT; Stávale JN; Gonçalves WJ
    Oncol Rep; 2007 Jul; 18(1):25-32. PubMed ID: 17549341
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunostaining Study on the Expression of NF-κB, ER, and PR in Ovarian Serous Carcinoma.
    Lin J; Xi C; Liu C; Wang Y; Liu Y; Ren C; Liu C
    Int J Gynecol Pathol; 2017 Jan; 36(1):58-63. PubMed ID: 27171541
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.